Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02983630 · ClinicalTrials.gov registry record
Allergy Testing of Patients Labeled as Penicillin Allergic
A clinical trial, sponsored by Albany Medical College.
- Completed
- Registry status
- 37
- Enrollment target
NCT02983630: Completed study, sponsored by Albany Medical College.
NCT02983630 is a clinical trial that has completed, run by Albany Medical College. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02983630 has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
Patients labeled as penicillin allergic, rarely have this confirmed and being labeled as "penicillin allergic" is associated with increased health care costs, adverse effects and antibiotic resistance. The investigators will recruit participants from primary care practices labeled as penicillin allergic and offer allergy testing. The aim of this study is to develop a community, outpatient program for evaluation of penicillin allergy.
Interventions
- OTHER Penicillin allergy testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-07-01 |
What the finished NCT02983630 record still lists
NCT02983630 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Penicillin allergy testing is the first listed.
NCT02983630 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02983630 about?
NCT02983630 is a clinical study titled "Allergy Testing of Patients Labeled as Penicillin Allergic". Patients labeled as penicillin allergic, rarely have this confirmed and being labeled as "penicillin allergic" is associated with increased health care costs, adverse effects and antibiotic resistance. The investigators will recruit participants from primary care practices labeled as penicillin alle...
What is the current status of trial NCT02983630?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2016-07. Estimated completion is 2017-07-01.
What interventions are being tested in trial NCT02983630?
The interventions under investigation include: Penicillin allergy testing (OTHER).
Who is sponsoring clinical trial NCT02983630?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia